Skip to main content

Table 1 Neurologic manifestations and neuroimaging findings in patients with GPA-related HCP

From: Clinical characteristics of hypertrophic cranial pachymeningitis in granulomatosis with polyangiitis: a retrospective single-center study in China

Number of patients

26

Neurologic involvement [n (%)]

 CNS involvement

26 (100.0%)

 PNS involvement

4 (15.4%)

 Neurologic involvement as initial manifestation

4 (15.4%)

Neurologic manifestations of CNS involvement [n (%)]

 Headache

26 (100.0%)

 Cranial nerve palsy

16 (61.5%)

Multiple CN involvement

 CN I

0 (0%)

 CN II

7 (26.9%)

 CN III

3 (11.5%)

 CN IV

2 (7.7%)

 CN V

6 (23.1%)

 CN VI

3 (11.5%)

 CN VII

7 (26.9%)

 CN VIII

5 (19.2%)

 CN IX

2 (7.7%)

 CN X

2 (7.7%)

 CN XI

0 (0%)

 CN XII

2 (7.7%)

 Pituitary involvement

4 (15.4%)

 Neuroimaging findings indicating HCP

26 (100.0%)

 Diffuse HCP

22 (84.6%)

Sites of HCP involvement [n (%)]

 Falx

5 (19.2%)

 Convexity

12 (46.2%)

 Tentorium

9 (34.6%)

 Skull base

11 (42.3%)

 Sellar region

2 (7.7%)

 CSF pressurea[mmH2O], median (IQR)

155 (125, 185)

 CSF proteinb[mg/dL], median (IQR)

49 (34.75, 65.25)

 CSF WBC countb[leukocytes/mm3], median (IQR)

2 (0, 6.75)

  1. GPA granulomatosis with polyangiit is, HCP hypertrophic cranial pachymeningitis, CNS central nervous system, PNS peripheral nervous system, CN central nerve, CSF cerebrospinal fluid, WBC white blood cells, IQR interquartile range
  2. aCSF pressure data available for 23 patients
  3. bCSF protein and CSF WBC count data available for 22 patients